ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      85.045
      0.31%
      Bitcoin
      65,038.93
      -0.15%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Idera Pharmaceuticals Inc (IDRA)

      7. Idera Pharmaceuticals Inc (IDRA) News

      IDRA

      Idera Pharmaceuticals (IDRA)

      Idera Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IDRA
      DateTimeSourceHeadlineSymbolCompany
      05/19/20207:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/19/20207:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/19/20207:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/19/20207:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/19/20206:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/19/20206:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/18/20208:00AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/14/20208:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/12/20204:33PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/07/20206:11AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/01/20208:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/01/20208:00AMGlobeNewswire Inc.Idera Pharmaceuticals Announces Change of Location for 2020 Annual Meeting of StockholdersNASDAQ:IDRAIdera Pharmaceuticals Inc
      05/01/20207:31AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/30/20204:35PMGlobeNewswire Inc.Idera Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
      04/30/20204:35PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/23/20207:30AMGlobeNewswire Inc.Idera Pharmaceuticals Announces Tilsotolimod Program Updates to be Presented at AACR Virtual Annual Meeting 2020NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/21/20208:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/21/20207:30AMGlobeNewswire Inc.Idera Pharmaceuticals Announces Final Clinical Safety and Efficacy Data from ILLUMINATE-204 Trial in Advanced MelanomaNASDAQ:IDRAIdera Pharmaceuticals Inc
      04/09/20206:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/07/20204:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/07/20204:05PMGlobeNewswire Inc.Idera Pharmaceuticals Announces Private Placement of up to $20.7 MillionNASDAQ:IDRAIdera Pharmaceuticals Inc
      04/06/20207:32AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/03/20205:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/03/20205:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/03/20205:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/03/20205:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/03/20205:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      03/25/20208:23AMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:IDRAIdera Pharmaceuticals Inc
      03/12/20207:49AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      03/12/20207:30AMGlobeNewswire Inc.Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:IDRA